Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.
Hayashi H, Chamoto K, Hatae R, Kurosaki T, Togashi Y, Fukuoka K, Goto M, Chiba Y, Tomida S, Ota T, Haratani K, Takahama T, Tanizaki J, Yoshida T, Iwasa T, Tanaka K, Takeda M, Hirano T, Yoshida H, Ozasa H, Sakamori Y, Sakai K, Higuchi K, Uga H, Suminaka C, Hirai T, Nishio K, Nakagawa K, Honjo T.
Hayashi H, et al. Among authors: yoshida h, yoshida t.
J Clin Invest. 2024 Apr 1;134(7):e168318. doi: 10.1172/JCI168318.
J Clin Invest. 2024.
PMID: 38557498
Free PMC article.